XmAb5871 suppressed B cell proliferation and antigen-presenting cell (APC) function by overcoming the FcγRIIb dysfunction of both SLE and rheumatoid arthritis (RA) B cells. This evidence concerns the gene FCGR2B and rheumatoid arthritis.